Managed Account Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$3.94M Sell
132,485
-15,013
-10% -$377K ﹤0.01% 1531
2015
Q1
$3.25M Sell
147,498
-26,512
-15% -$673K ﹤0.01% 1632
2014
Q4
$4.78M Buy
174,010
+174,007
+5,800,233% +$4.23M ﹤0.01% 1426
2014
Q3
$0 Hold
3
﹤0.01% 2686
2014
Q2
$0 Hold
3
﹤0.01% 2644
2014
Q1
$0 Sell
3
-10,004
-100% -$135K ﹤0.01% 2630
2013
Q4
$118K Sell
10,007
-70,827
-88% -$813K ﹤0.01% 2283
2013
Q3
$954K Buy
80,834
+68,684
+565% +$881K ﹤0.01% 1896
2013
Q2
$169K Buy
+12,150
New +$132K ﹤0.01% 2169

Other funds holding EXAS

Managed Account Advisors's EXAS Position: Q2 2015 in Review

Managed Account Advisors reduced its Exact Sciences (EXAS) stake by 10% in Q2 2015, selling an estimated $377K and leaving 132,485 shares worth $3.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1531.

Managed Account Advisors first reported a position in EXAS in Q2 2013 and has held it in 9 quarters since. The position peaked at $4.78M in Q4 2014. 203 funds tracked by Wall St. Rank hold EXAS as of Q2 2015.

  • Managed Account Advisors held 132,485 shares of Exact Sciences worth $3.94M as of Q2 2015.
  • Managed Account Advisors sold 15,013 Exact Sciences shares in Q2 2015, an estimated $377K.
  • Exact Sciences made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1531 holding.
  • Managed Account Advisors first reported a position in Exact Sciences in Q2 2013 and has held it in 9 quarters since.
  • Managed Account Advisors's Exact Sciences position peaked at $4.78M in Q4 2014.
  • 203 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.